ZBNA
PRAX icon

Zions Bancorporation, National Association’s Praxis Precision Medicines PRAX Stock Holding History

Zions Bancorporation, National Association’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
3
+1
+50% +$317 ﹤0.01% 1419
2026
Q1 		$644 Buy
+2
New +$619 ﹤0.01% 1406

Other funds holding PRAX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Zions Bancorporation, National Association's PRAX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Praxis Precision Medicines (PRAX) stake by 50% in Q2 2026, buying an estimated $317 and bringing the position to 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Zions Bancorporation, National Association first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Zions Bancorporation, National Association held 3 shares of Praxis Precision Medicines worth $1K as of Q2 2026.
  • Zions Bancorporation, National Association bought 1 Praxis Precision Medicines share in Q2 2026, an estimated $317.
  • Praxis Precision Medicines made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1419 holding.
  • Zions Bancorporation, National Association first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.